This website is intended for the UK-based adult patients
living with type 2 diabetes who have been prescribed Ozempic® (semaglutide injection).
Welcome to Ozempic® (semaglutide injection)
Welcome to the Ozempic®
UK Patient Website
Welcome! You are here either because you are an adult patient living with type 2 diabetes who has been prescribed Ozempic® or you are a carer of an adult patient living with type 2 diabetes who has been prescribed Ozempic®.
This website has been developed by Novo Nordisk UK to provide a range of resources to support your use of Ozempic®.
This information does not replace the Patient Information Leaflet, which you are advised to read in full. It is not intended as a substitute for clinical advice provided by your healthcare professional. Please contact your healthcare professional if you have any questions about your treatment and for clinical advice.
For information on reporting side effects please see the bottom of this page.
In the links below you can access the Ozempic® Patient Information Leaflets, which can be found on the electronic medicines compendium (eMC):
Why have you been prescribed Ozempic® and what is it?
Having type 2 diabetes means that managing your blood sugar levels is very important. You and your healthcare professional have decided that Ozempic® is the appropriate medication to help you do this.
Ozempic® contains the active substance semaglutide. It helps your body reduce your blood sugar level only when blood sugar is too high and can help prevent heart disease in patients with type 2 diabetes. It also helps to slow down deterioration of kidney function in patients with type 2 diabetes by a mechanism beyond blood glucose lowering.
Ozempic® is used to treat adults (aged 18 years and older) with type 2 diabetes when diet and exercise is not enough:
- on its own – when you cannot use metformin (another diabetes medicine) or
- with other medicines for diabetes – when they are not enough to control your blood sugar levels. These may be medicines you take by mouth or inject such as insulin.
It is important that you continue with your diet and exercise plan as told by your doctor, pharmacist or nurse.
Resources to support you with your Ozempic® treatment
This video provides instructions on how to use the Ozempic® pen and how to inject. Please refer to the Ozempic® Patient Information Leaflets for full instructions about using the Ozempic® pen. Please speak with your healthcare professional if you have any additional questions or queries.
Please ensure to check your Ozempic® pens before use.
Always dispose of the needle immediately after each injection using a sharps bin. Never store your pen with the needle attached. Keep your sharps bin in a safe place so it’s not a risk to other people and is out of the sight and reach of children. Sharps bins must not be disposed of in household waste. Discuss with your healthcare professional the procedure for disposing of sharps bins in your area.
We have developed a digital booklet with you in mind to support you throughout your Ozempic® treatment. It will give you information about Ozempic®, an explanation of how Ozempic® works and some things to remember when using Ozempic®.
If there are any words in this digital booklet that are new or difficult to understand, please look at the section called 'Useful words to know.'
If you still have any questions or queries, please speak with your healthcare professional.
Reporting of side effects
If you get any side effects, talk to your doctor, pharmacist or nurse. This includes any possible side effects not listed in the Patient Information Leaflet. You can also report side effects directly via the Yellow Card Scheme at yellowcard.mhra.gov.uk. Side effects should also be reported to Novo Nordisk Limited (Telephone Novo Nordisk Customer Care Centre 0800 023 2573). Calls may be monitored for training purposes. By reporting side effects, you can help provide more information on the safety of this medicine.
See yellowcard.mhra.gov.uk for how to report side effects.